Alpelisib Completed Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01387321A Study of BYL719 in Adult Patients With Advanced Solid Malignancies